Yanhong Deng Selected Research

Portal Hypertension

12/2022	Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: Validation of ANTICIPATE models and development of a lab-based model.
10/2021	Thick Fibrous Septa on Liver Biopsy Specimens Predict the Development of Decompensation in Patients With Compensated Cirrhosis.
1/2021	Sleep Disturbance Is Associated With the Presence of Portosystemic Collaterals in Patients With Compensated Cirrhosis.
1/2018	Transjugular intrahepatic portosystemic shunt creation for cirrhotic portal hypertension is well tolerated among patients with portal vein thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yanhong Deng Research Topics

Disease

52	Neoplasms (Cancer) 04/2024 - 07/2008
43	Colorectal Neoplasms (Colorectal Cancer) 04/2024 - 06/2009
30	Rectal Neoplasms (Rectal Cancer) 03/2024 - 02/2014
13	Neoplasm Metastasis (Metastasis) 04/2024 - 07/2015
10	Infections 12/2023 - 04/2011
10	Fibrosis (Cirrhosis) 10/2023 - 11/2013
7	Inflammation (Inflammations) 01/2022 - 11/2013
6	Pathologic Complete Response 04/2024 - 01/2016
6	Hypertension (High Blood Pressure) 11/2021 - 01/2020
6	Acute Lung Injury 06/2015 - 04/2012
5	Colonic Neoplasms (Colon Cancer) 04/2024 - 02/2013
5	Microsatellite Instability 03/2024 - 01/2021
5	Disease Progression 02/2024 - 04/2017
5	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 11/2023 - 01/2013
5	Fatigue 11/2023 - 12/2015
5	COVID-19 01/2023 - 10/2020
4	Low Anterior Resection Syndrome 03/2024 - 03/2019
4	Adenocarcinoma 02/2024 - 04/2017
4	Autoimmune Hepatitis 01/2023 - 01/2016
4	Portal Hypertension 12/2022 - 01/2018
4	Autism Spectrum Disorder 11/2021 - 03/2013
4	Hemorrhage 08/2021 - 04/2012
4	Lung Neoplasms (Lung Cancer) 01/2020 - 01/2013
3	Familial Hypophosphatemic Rickets (X-Linked Hypophosphatemia) 02/2024 - 01/2018
3	Pain (Aches) 02/2024 - 06/2022
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2023 - 01/2020
3	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 11/2016
3	Proteinuria 08/2021 - 11/2020
3	Carcinoma (Carcinomatosis) 02/2021 - 01/2020
3	Liver Diseases (Liver Disease) 11/2019 - 11/2013
3	Asthma (Bronchial Asthma) 06/2015 - 09/2011
3	Pulmonary Edema 06/2013 - 04/2012
2	Parkinson Disease (Parkinson's Disease) 05/2024 - 11/2023
2	Hypophosphatemia 02/2024 - 11/2023
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2018
2	Obesity 10/2023 - 01/2022
2	Insulin Resistance 10/2023 - 01/2016
2	Sclerosing Cholangitis 01/2023 - 02/2017
2	Fistula 01/2023 - 01/2022
2	Non-alcoholic Fatty Liver Disease 12/2022 - 01/2016
2	Anastomotic Leak 11/2022 - 10/2016
2	Hepatitis C 05/2022 - 01/2015
2	End Stage Liver Disease 10/2021 - 05/2017
2	Thrombophilia 10/2021 - 10/2020

Drug/Important Bio-Agent (IBA)

17	Fluorouracil (Carac)FDA LinkGeneric 04/2024 - 11/2014
15	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2024 - 11/2014
11	Proteins (Proteins, Gene)FDA Link 01/2023 - 04/2011
11	Bevacizumab (Avastin)FDA Link 02/2022 - 07/2015
10	Biomarkers (Surrogate Marker)IBA 10/2023 - 05/2014
8	Leucovorin (Folinic Acid)FDA Link 04/2024 - 01/2016
8	Irinotecan (Camptosar)FDA LinkGeneric 01/2024 - 11/2014
6	HMPL-013IBA 04/2024 - 01/2018
6	Immune Checkpoint InhibitorsIBA 01/2024 - 01/2018
5	CytokinesIBA 04/2024 - 11/2013
5	Capecitabine (Xeloda)FDA Link 04/2024 - 12/2016
4	Alanine Transaminase (SGPT)IBA 12/2021 - 01/2016
3	Phosphates (Orthophosphate)IBA 02/2024 - 04/2012
3	Circulating Tumor DNAIBA 02/2024 - 01/2018
3	Monoclonal AntibodiesIBA 01/2024 - 01/2021
3	Tyrosine Kinase InhibitorsIBA 11/2023 - 12/2020
3	Imatinib Mesylate (Gleevec)FDA Link 02/2023 - 01/2013
3	RNA (Ribonucleic Acid)IBA 01/2023 - 11/2019
3	Messenger RNA (mRNA)IBA 08/2022 - 01/2013
3	Aspartate Aminotransferases (Aspartate Transaminase)IBA 12/2021 - 10/2020
3	Cetuximab (Erbitux)FDA Link 01/2021 - 11/2015
3	Carcinoembryonic AntigenIBA 11/2018 - 08/2015
3	Peroxidase (Myeloperoxidase)IBA 06/2013 - 04/2012
2	Indicators and Reagents (Reagents)IBA 01/2024 - 01/2021
2	renalaseIBA 12/2023 - 01/2022
2	FlavonoidsIBA 12/2023 - 04/2012
2	Calcibiotic Root Canal SealerIBA 12/2023 - 01/2023
2	avapritinibIBA 11/2023 - 01/2023
2	Polystyrenes (Polystyrene)IBA 11/2023 - 01/2023
2	COVID-19 VaccinesIBA 10/2023 - 06/2022
2	LeptinIBA 10/2023 - 01/2016
2	N-acetyltalosaminuronic acid (NAT)IBA 02/2023 - 01/2018
2	Interleukin-17 (Interleukin 17)IBA 01/2023 - 01/2016
2	Antineoplastic Agents (Antineoplastics)IBA 01/2023 - 08/2019
2	B7-H1 AntigenIBA 01/2023 - 01/2021
2	BilirubinIBA 01/2023 - 10/2020
2	4-(3-chlorophenylsulfanyl)piperidineIBA 12/2022 - 10/2021
2	VaccinesIBA 08/2022 - 06/2022
2	Neutralizing AntibodiesIBA 06/2022 - 04/2013
2	Antiviral Agents (Antivirals)IBA 05/2022 - 11/2019
2	Celecoxib (Celebrex)FDA Link 01/2022 - 02/2013
2	LigandsIBA 12/2021 - 06/2020
2	Tretinoin (Retinoic Acid)FDA LinkGeneric 12/2021 - 02/2017
2	AlbuminsIBA 10/2021 - 10/2020
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 10/2021 - 01/2013
2	tocilizumab (atlizumab)FDA Link 10/2021 - 10/2020

Therapy/Procedure

41	Therapeutics 02/2024 - 07/2008
33	Drug Therapy (Chemotherapy) 01/2023 - 02/2013
28	Neoadjuvant Therapy 04/2024 - 04/2013
11	Chemoradiotherapy 03/2024 - 11/2014
8	Radiotherapy 02/2024 - 01/2016
6	Immunotherapy 10/2023 - 01/2018
6	Adjuvant Chemotherapy 01/2020 - 08/2013
4	Proctectomy 03/2024 - 06/2015
3	Liver Transplantation 01/2019 - 01/2018
2	Artificial Respiration (Mechanical Ventilation) 01/2023 - 10/2020